Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 141

1.

Blood pressure measurement reliability among different racial-ethnic groups in a stroke prevention study.

Estol CJ, Bath PM, Gorelick PB, Cotton D, Martin RH, Weber MA, Dahlof B; PRoFESS Publications Committee; PRoFESS Investigators.

Blood Press Monit. 2014 Oct;19(5):256-62. doi: 10.1097/MBP.0000000000000045.

PMID:
24736279
2.

Differences in ischemic and hemorrhagic recurrence rates among race-ethnic groups in the PRoFESS secondary stroke prevention trial.

Estol CJ, Bath PM, Gorelick PB, Cotton D, Martin RH; PRoFESS Publications Committee and PRoFESS Investigators.

Int J Stroke. 2014 Oct;9 Suppl A100:43-7. doi: 10.1111/ijs.12269. Epub 2014 Mar 18.

PMID:
24636673
3.

Response: Blood pressure measurement reliability among different racial-ethnic groups in a stroke prevention study: methodological issues that strengthen our results.

Estol CJ, Cotton D, Gorelick PB.

Blood Press Monit. 2015 Jun;20(3):168-9. doi: 10.1097/MBP.0000000000000099. No abstract available.

PMID:
25943468
4.

Blood pressure measurement reliability among different racial-ethnic groups in a stroke prevention study: methodological issues to avoid misinterpretation.

Sabour S.

Blood Press Monit. 2015 Jun;20(3):168. doi: 10.1097/MBP.0000000000000098. No abstract available.

PMID:
25943467
5.

Comparative antihypertensive efficacy of angiotensin receptor blocker-based treatment in African-American and white patients.

Bakris GL, Smith DH, Giles TD, White WB, Davidai G, Weber MA.

J Clin Hypertens (Greenwich). 2005 Oct;7(10):587-95; quiz 596-7.

6.

Effects of telmisartan and amlodipine in combination on ambulatory blood pressure in stages 1-2 hypertension.

White WB, Littlejohn TW, Majul CR, Oigman W, Olvera R, Seeber M, Schumacher H, Mancia G.

Blood Press Monit. 2010 Aug;15(4):205-12. doi: 10.1097/MBP.0b013e32833c5722.

PMID:
20613496
7.

Effects of the angiotensin II receptor blockers telmisartan versus valsartan in combination with hydrochlorothiazide: a large, confirmatory trial.

White WB, Murwin D, Chrysant SG, Koval SE, Davidai G, Guthrie R.

Blood Press Monit. 2008 Feb;13(1):21-7. doi: 10.1097/MBP.0b013e3282f3859d. Erratum in: Blood Press Monit. 2008 Aug;13(4):241.

PMID:
18199920
8.

Comparison of trough effect of telmisartan vs perindopril using self blood pressure measurement: EVERESTE study.

Ragot S, Ezzaher A, Meunier A, Poterre M, Bourkaib R, Herpin D.

J Hum Hypertens. 2002 Dec;16(12):865-73.

9.

Efficacy and tolerability of initial therapy with single-pill combination telmisartan/hydrochlorothiazide 80/25 mg in patients with grade 2 or 3 hypertension: a multinational, randomized, double-blind, active-controlled trial.

Zhu DL, Bays H, Gao P, Mattheus M, Voelker B, Ruilope LM.

Clin Ther. 2012 Jul;34(7):1613-24. doi: 10.1016/j.clinthera.2012.05.007. Epub 2012 Jun 19.

PMID:
22717420
10.

Telmisartan 80 mg/hydrochlorothiazide 25 mg provides clinically relevant blood pressure reductions across baseline blood pressures.

Neldam S, Schumacher H, Guthrie R.

Adv Ther. 2012 Apr;29(4):327-38. doi: 10.1007/s12325-012-0013-0. Epub 2012 Apr 3.

PMID:
22477543
11.

Telmisartan on top of antihypertensive treatment does not prevent progression of cerebral white matter lesions in the prevention regimen for effectively avoiding second strokes (PRoFESS) MRI substudy.

Weber R, Weimar C, Blatchford J, Hermansson K, Wanke I, Möller-Hartmann C, Gizewski ER, Forsting M, Demchuk AM, Sacco RL, Saver JL, Warach S, Diener HC, Diehl A; PRoFESS Imaging Substudy Group.

Stroke. 2012 Sep;43(9):2336-42. Epub 2012 Jun 26.

PMID:
22738922
12.

Telmisartan and stroke reduction in the ONTARGET trial: benefit beyond blood pressure lowering?

Serebruany VL, Atar D, Hanley DF.

Cerebrovasc Dis. 2008;26(5):563-4. doi: 10.1159/000164555. Epub 2008 Oct 21. No abstract available.

14.

Dialysis-associated hypertension treated with Telmisartan--DiaTel: a pilot, placebo-controlled, cross-over, randomized trial.

Huber M, Treutler T, Martus P, Kurzidim A, Kreutz R, Beige J.

PLoS One. 2013 Nov 18;8(11):e79322. doi: 10.1371/journal.pone.0079322. eCollection 2013.

15.

The angiotensin II receptor antagonist telmisartan reduces urinary albumin excretion in patients with isolated systolic hypertension: results of a randomized, double-blind, placebo-controlled trial.

Vogt L, Navis G, Köster J, Manolis AJ, Reid JL, de Zeeuw D; Angiotensin II Receptor Antagonist Telmisartan Micardis in Isolated Systolic Hypertension (ARAMIS) Study Group.

J Hypertens. 2005 Nov;23(11):2055-61.

PMID:
16208149
16.

[Influence of blood pressure variability during office visit on the estimation of blood pressure control in treated hypertensive patients].

Villeneuve F, Rosenbaum D, Gury C, Girerd X.

Ann Cardiol Angeiol (Paris). 2012 Jun;61(3):198-202. doi: 10.1016/j.ancard.2012.04.022. Epub 2012 May 23. French.

PMID:
22677179
17.
18.

Combination of amlodipine plus angiotensin receptor blocker or diuretics in high-risk hypertensive patients: a 96-week efficacy and safety study.

Ma L, Wang W, Zhao Y, Zhang Y, Deng Q, Liu M, Sun H, Wang J, Liu L.

Am J Cardiovasc Drugs. 2012 Apr 1;12(2):137-42. doi: 10.2165/11598110-000000000-00000.

PMID:
22329591
19.
20.

Single-pill combination of telmisartan/amlodipine versus amlodipine monotherapy in diabetic hypertensive patients: an 8-week randomized, parallel-group, double-blind trial.

Sharma AM, Bakris G, Neutel JM, Littlejohn TW, Kobe M, Ting N, Ley L.

Clin Ther. 2012 Mar;34(3):537-51. doi: 10.1016/j.clinthera.2012.02.004. Epub 2012 Mar 3.

PMID:
22386829

Supplemental Content

Support Center